AI Summary
The article discusses the use of artificial intelligence (AI) in prostate cancer detection on MRI, comparing its performance to radiologists using PI-RADS. The study found that the AI system was superior to radiologists in detecting clinically significant prostate cancer and comparable to the standard of care. This suggests that AI has the potential to be a valuable supportive tool in primary diagnostic settings, offering benefits for patients and radiologists. Further prospective validation is necessary to determine the clinical applicability of this AI system.
An AI system was superior to radiologists using PI-RADS (2.1), on average, at detecting clinically significant prostate cancer and comparable to the standard of care. Such a system shows the potential to be a supportive tool within a primary diagnostic setting, with several associated benefits for patients and radiologists. Prospective validation is needed to test clinical applicability of this system.